Literature DB >> 7835960

A role for CD4+ T cells from orally immunized rats in enhanced clearance of Pseudomonas aeruginosa from the lung.

M L Dunkley1, R L Clancy, A W Cripps.   

Abstract

The role of gut-derived CD4+ T cells in clearance of Pseudomonas aeruginosa from the lung was studied by cell transfer experiments. Mesenteric lymph node cells from unimmunized rats, or rats orally immunized with either killed P. aeruginosa or Helicobacter pylori, were transferred to naive rats which were subsequently challenged intra-tracheally with live P. aeruginosa. Recipients of unseparated mesenteric lymph node cells, purifed T cells or CD4+ T cells, from P. aeruginosa-immunized donors, all exhibited enhanced bacterial clearance from the airways compared to recipients of cells from unimmunized donors. Enhanced clearance by T cells was antigen-specific as no enhanced clearance was observed by transfer of cells from donors immunized with H. pylori.

Entities:  

Mesh:

Year:  1994        PMID: 7835960      PMCID: PMC1415036     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Molecular and antigenic heterogeneity of the rat leukocyte-common antigen from thymocytes and T and B lymphocytes.

Authors:  G R Woollett; A N Barclay; M Puklavec; A F Williams
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

2.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

Review 4.  Functions of rat T-lymphocyte subsets isolated by means of monoclonal antibodies.

Authors:  D W Mason; R P Arthur; M J Dallman; J R Green; G P Spickett; M L Thomas
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

5.  T-lymphocyte heterogeneity in the rat: separation of functional subpopulations using a monoclonal antibody.

Authors:  R A White; D W Mason; A F Williams; G Galfre; C Milstein
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

6.  In vitro T cell-mediated killing of Pseudomonas aeruginosa. I. Evidence that a lymphokine mediates killing.

Authors:  R B Markham; J Goellner; G B Pier
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

7.  Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.

Authors:  G Döring; N Høiby
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine.

Authors:  G B Pier; R B Markham
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

9.  Two subsets of rat T lymphocytes defined with monoclonal antibodies.

Authors:  R J Brideau; P B Carter; W R McMaster; D W Mason; A F Williams
Journal:  Eur J Immunol       Date:  1980-08       Impact factor: 5.532

10.  Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats.

Authors:  A W Cripps; M L Dunkley; R L Clancy
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

View more
  27 in total

1.  CD8+ T cells have an essential role in pulmonary clearance of nontypeable Haemophilus influenzae following mucosal immunization.

Authors:  A R Foxwell; J M Kyd; G Karupiah; A W Cripps
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.

Authors:  T K Kondratieva; N V Kobets; S V Khaidukov; V V Yeremeev; I V Lyadova; A S Apt; M F Tam; M M Stevenson
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.

Authors:  Gregory P Priebe; Rebecca L Walsh; Terra A Cederroth; Akinobu Kamei; Yamara S Coutinho-Sledge; Joanna B Goldberg; Gerald B Pier
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 4.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 5.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

6.  Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells.

Authors:  S Worgall; T Kikuchi; R Singh; K Martushova; L Lande; R G Crystal
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

7.  Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.

Authors:  Rika Gomi; Anurag Sharma; Wenzhu Wu; Biin Sung; Stefan Worgall
Journal:  Vaccine       Date:  2017-11-07       Impact factor: 3.641

8.  Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.

Authors:  Stefan Worgall; Anja Krause; Michael Rivara; Kyung-Kim Hee; Enrico V Vintayen; Neil R Hackett; Peter W Roelvink; Joseph T Bruder; Thomas J Wickham; Imre Kovesdi; Ronald G Crystal
Journal:  J Clin Invest       Date:  2005-04-01       Impact factor: 14.808

9.  Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa.

Authors:  D Gosselin; J DeSanctis; M Boulé; E Skamene; C Matouk; D Radzioch
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Nontypeable Haemophilus influenzae: pathogenesis and prevention.

Authors:  A R Foxwell; J M Kyd; A W Cripps
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.